SHANTON PHARMA CO LTD has a total of 15 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2016. It filed its patents most often in Hong Kong, Singapore and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are JONES PHILIP, GENOSCIENCE PHARMA and CARNA BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Hong Kong | 2 | |
#2 | Singapore | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EAPO (Eurasian Patent Organization) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Taiwan | 1 | |
#11 | United States | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Qian | 12 |
#2 | Liu Jinrong | 12 |
#3 | Huang Zhenhua | 12 |
#4 | Chi Shuangshuang | 12 |
#5 | Qian Zhang | 3 |
#6 | Jinrong Liu | 3 |
#7 | Zhenhua Huang | 3 |
#8 | Shuangshuang Chi | 3 |
Publication | Filing date | Title |
---|---|---|
BR112017016065A2 | prevention or treatment of uric acid or gouty disease |